Manufacturer: Torrent Pharma
Pharmaceutical name: Repaglinide
Pack: 10 pills (0.5 mg)
Eurepa is utilized for managing type 2 diabetes, a condition where the body struggles to properly use insulin, leading to difficulties in controlling blood sugar levels. Eurepa aids in regulating the glucose (sugar) levels in your bloodstream by prompting the pancreas to secrete insulin, thereby reducing the overall glucose amounts.
Eurepa is classified as a meglitinide medication. It is taken orally in conjunction with a prescribed diet, exercise, and significant lifestyle modifications to achieve optimal results. It is vital to refrain from smoking and limit alcohol consumption during and after the treatment process. Additionally, managing stress is crucial, as it can significantly influence blood sugar levels. Eurepa is indicated for controlling blood sugar levels and treating Type 2 Diabetes mellitus by encouraging the body to increase insulin production, which helps to lower and normalize glucose levels. This medication also diminishes the risk of kidney failure and cardiovascular issues. However, Eurepa is not suitable for individuals with Type 1 Diabetes or diabetic ketoacidosis, nor is it recommended for those who have hypersensitivity or allergies to any components of the medication.
Usage of Eurepa may lead to certain adverse side effects. If symptoms persist or discomfort intensifies, it is advised to seek medical attention promptly. Some potential side effects include blurred vision, vomiting, diarrhea, headache, respiratory infections, sinusitis, rhinitis, constipation, and pain or swelling in muscles or joints.